FDA gives HDE (humanitarian device exemption) approval for gastric stimulation system
This article was originally published in Clinica
The US FDA has approved Medtronic's implantable electrical stimulation device for treating patients with a rare but severe and often life-threatening form of gastroparesis, a gastrointestinal disorder marked by chronic vomiting and nausea.
You may also be interested in...
As part of a periodic review, FDA is bringing together experts to review several products that are conditionally available for pediatric use under the agency's Humanitarian Device Exemption program.
South Korea has formulated new detailed policy measures to support the formation of major bioclusters, which will offer tax and other incentives in a bid to lure foreign firms and talent.
Abrysvo is recommended for use in pregnant people 32-36 weeks gestation if administered from September to January. For infants whose mothers were not vaccinated in this window, nirsevimab is recommended for prevention of respiratory syncytial virus infection.